Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Baxter International ( (BAX) ) just unveiled an announcement.
On January 31, 2025, Baxter International Inc. completed the sale of several entities, including Vantive Health LLC and Gambro Renal Products, to a consortium of buyers for approximately $3.71 billion in cash after adjustments. This transaction marks a significant divestment for Baxter, likely impacting its strategic focus and operations, as well as the stakeholders involved, including the transition of Chris Toth from his executive roles.
More about Baxter International
YTD Price Performance: 11.28%
Average Trading Volume: 4,730,978
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.62B
Find detailed analytics on BAX stock on TipRanks’ Stock Analysis page.
